A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
St. Justine's Hospital
Eastern Cooperative Oncology Group
The Children's Hospital of Zhejiang University School of Medicine
Essen Biotech
University of Nebraska
Adela, Inc
Memorial Sloan Kettering Cancer Center
University Health Network, Toronto
Children's Oncology Group
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Barbara Ann Karmanos Cancer Institute
Region Skane
Rigshospitalet, Denmark
Tempus AI
Children's Oncology Group
Institut Curie
Cedars-Sinai Medical Center
Dana-Farber Cancer Institute
Martin-Luther-Universität Halle-Wittenberg
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Medical University of Vienna
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Children's Hospital Medical Center, Cincinnati
St. Jude Children's Research Hospital
Celgene
Rutgers, The State University of New Jersey
Northwestern University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Celgene
National Institutes of Health Clinical Center (CC)
Acrotech Biopharma Inc.
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
University of Michigan Rogel Cancer Center
Columbia University
Albert Einstein College of Medicine
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute